ClinicalTrials.Veeva

Menu

Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Multiple Myeloma
Stem Cell Transplant

Treatments

Behavioral: Pack Health's Digital Life Coaching (DLC)
Other: Electronic Handouts

Study type

Interventional

Funder types

Other

Identifiers

NCT04589286
202511
NCI-2020-08100 (Registry Identifier)

Details and patient eligibility

About

Autologous stem cell transplantation (SCT) is the standard of care for fit multiple myeloma (MM) patients; however, the first 100 days after SCT are marked by extensive life disruptions. We have found a 56% relative increase in the use of high-risk benzodiazepine and Z-class (B/Z) drugs for anxiety and insomnia among MM patients during this period. Digital life coaching (DLC), whereby trained coaches work longitudinally with patients through phone calls and text messages to accomplish personal goals, may be able to target anxiety and insomnia in a more integrative manner. This study will investigate whether peri-SCT DLC can lower B/Z usage and improve patient-reported well-being.

Full description

This is a single-center, Phase II randomized study of MM patients comparing 16 weeks of DLC access versus quasi-usual care (quasi-usual because both arms will receive generic wellness-related electronic handouts alongside requests for patient-reported outcome (PRO) assessments).

Primary Objective:

To evaluate DLC's impact on B/Z drug usage (excluding lorazepam prescribed for chemotherapy-induced nausea/vomiting, or CINV)

Secondary Objectives:

  1. To evaluate DLC's impact on patient-reported general quality of life every 1-2 weeks
  2. To evaluate DLC's impact on patient-reported psychosocial distress every 1-2 weeks
  3. To evaluate DLC's impact on patient-reported insomnia every 1-2 weeks

Exploratory Objectives:

  1. To explore DLC's impact on rates of communications between patients and their treatment teams
  2. To explore DLC's impact on clinical outcomes

Participants may continue study treatment (DLC platform access) for 16 weeks from the time of initiating treatment. Participants will not be contacted by the DLC platform vendor after this point. Patients will be followed up at Day +101 after SCT, corresponding to approximately 3 months after SCT.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed diagnosis of one of the following (all referred to as multiple myeloma (MM) for the purposes of this protocol):

    • Multiple myeloma (ICD-10 code: C90.0)
    • Extramedullary plasmacytoma (ICD-10 code: C90.2)
  • Planned receipt of autologous stem cell transplantation (SCT) at University of California, San Francisco (UCSF)

    • Patients undergoing outpatient SCT will be eligible
    • Patients who received chemomobilization will be eligible
  • Ability to understand a written informed consent form (ICF) document, and the willingness to sign the ICF document

Exclusion criteria

  • Age < 18 years
  • SCT as salvage therapy
  • Patient-assessed lack of sufficient English proficiency
  • Lack of ownership of a personal smartphone

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Pack Health's Digital Life Coaching (DLC)
Experimental group
Description:
Participants will receive 16 weeks of access to a trained human life coach employed by Pack Health. Coaches will communicate via phone calls, text messages, emails, and links to web-based Pack Health resources plus the addition of generic wellness-related electronic handouts at the time of each email reminder for participant-reported outcome (PRO) assessments
Treatment:
Behavioral: Pack Health's Digital Life Coaching (DLC)
Other: Electronic Handouts
Quasi-usual care control arm
Active Comparator group
Description:
Participants will receive usual supportive care for stem cell transplantation plus the addition of generic wellness-related electronic handouts at the time of each email reminder for participant-reported outcome (PRO) assessments
Treatment:
Other: Electronic Handouts

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems